Most just lately, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to the wide array of endogenous opioids. As opposed to most opioid receptors, this receptor functions to be a scavenger and does